glp-1 overview Safety and Tolerability of Glucagon-Like
Description
Diabetes Obes Metab (2018) 20(2):46873
122 While the triagonist reduced ovarian weight and LH levels in one model, it did not restore ovarian cyclicity or histological markers of ovarian function in either PCOS model
Microorganisms, 9(5), 1098
This lowers blood glucose levels by mobilising glucose molecules into the liver as well as adipose tissue and muscles
